Home / People / Dr. Thomas Hirse
Thomas Hirse

Dr. Thomas Hirse


CMS Hasche Sigle
Breite Straße 3
40213 Duesseldorf
Languages German, English

Thomas Hirse has particular experience with the legal evaluation of intellectual property in the context of corporate transactions and IPOs. He regularly advises on technology-driven mergers and acquisitions in the life sciences and biotech sector, mechanical and plant engineering as well as automotive industry. Thomas furthermore advises clients across a variety of industry sectors on an ongoing basis on patent and utility patent law, including all related antitrust law aspects and questions related to employee inventions. He has successfully drafted and negiotiated numerous R&D and licence agreements and also represents his clients in international disputes and acts as counsel in arbitration proceedings.

Thomas started his legal career with Linklaters in 2006 and joined CMS in 2007. He has been a partner since 2014.

more less


  • 2005: PhD; thesis on international private law

  • 2003 - 2005: Trainee lawyer at Wuppertal Regional Court

  • 2001 - 2002: Friedrich Naumann Foundation PhD scholar

  • 2001 - 2002: Worked as legal expert for Arbeitsgemeinschaft der Verbraucherverbände e.V. in the context of the legislative process for the reform of the German law of obligations

  • 2000 - 2002: Research assistant to a Higher Regional Court judge and to Prof. Dr. Harald Koch, Chair for Civil Law, Civil Procedure Law, International Private Law and Comparative Law

  • 1995 - 2000: Law studies at the University of Rostock

more less


  • Schriftenreihe des Max-Planck-Instituts für auslaendisches und internationales Privatrecht, Die Ausweichklausel im Internationalen Privatrecht - Methodentheoretische und -kritische Gedanken zu einer besonderen kollisionsrechtlichen Generalklausel, Mohr Siebeck Tübingen 2007

  • Kothe/Micklitz/Rott/Tonner/Willingmann; Das neue Schuldrecht - Kompaktkommentar, Kommentierung der Regelungen zum Leistungsstoerungs-und Ruecktrittsfolgenrecht, Luchterhand 2003

  • Beitraege zur Neuregelung des Leistungsstoerungsrechts im Rahmen der Schuldrechtsmodernisierung, VuR 2001, p. 99 ff

  • Die Prozessfuehrung durch den Versicherer (zus. mit Prof. Dr. Harald Koch), VersR 2001

  • Anmerkungen und Beitraege zu verschiedenen BGH-Entscheidungen zum Folgekostenstreit bei straßenbaubedingter Verlegung von Versorgungsleitungen in den neuen Bundeslaendern, NJ 2001, p. 459 ff

more less


Show only
CMS ad­vises in­dus­tri­al hold­ing com­pany Armira on in­vest­ment...
Ger­man con­sti­tu­tion­al chal­lenge to UPCA: new back­ground in­form­a­tion
The Ger­man Con­sti­tu­tion­al Court (the “Court”) has stopped the rat­i­fic­a­tion of the Agree­ment on a Uni­fied Pat­ent Court (the “UPCA”) dur­ing pre­lim­in­ary pro­ceed­ings due to a con­sti­tu­tion­al chal­lenge made by an un­known ap­plic­ant.
CMS ad­vises Au­gur on sale of Ver­itas Group to La Française
HIV drug re­ceives pro­vi­sion­al com­puls­ory pat­ent li­cense
On 11 Ju­ly 2017, the Bundes­gericht­shof (Ger­man Fed­er­al Court of Justice, “FCJ”), Ger­many’s highest civil court, up­held the de­cision of the Bundes­pat­ent­gericht (Fed­er­al Pat­ent Court, “FPC”) grant­ing a pro­vi­sion­al com­puls­ory pat­ent li­cense for an HIV drug by.
Bruker Cor­por­a­tion ad­vised by CMS on ac­quis­i­tion of...
More bad news for the European Unit­ary Pat­ent: The Fed­er­al Con­sti­tu­tion­al...
The Bundestag and Bundes­rat have passed Ger­man laws on the European pat­ent with unit­ary ef­fect (the “European Unit­ary Pat­ent”) and the Unit­ary Pat­ent Court (the “UPC”). These laws, which still have to be signed by the Ger­man Pres­id­ent, should have been im­ple­men­ted.
CMS Glob­al Lifes­ci­ences For­um 2015 in Frank­furt
The fu­ture of the European Unit­ary Pat­ent – dark clouds on the ho­ri­zon?
The art of proph­ecy is very dif­fi­cult, es­pe­cially with re­spect to the fu­ture. Pre­dict­ing the fu­ture of the European Unit­ary Pat­ent - and the UK's po­s­i­tion on it - is no ex­cep­tion. In March 2017, the UK In­tel­lec­tu­al Prop­erty Of­fice men­tioned that the im­ple­ment­a­tion.
February 2015
Un­der the Mi­cro­scope
High­er Re­gion­al Court of Düs­sel­dorf ad­dresses FRAND terms in pat­ent...
In the af­ter­math of the Court of Justice of the European Uni­on’s (the “CJEU”) de­cision in Hua­wei Tech­no­lo­gies v ZTE, the High­er Re­gion­al Court of Düs­sel­dorf has ruled on the ob­lig­a­tions of a stand­ard es­sen­tial pat­ent (“SEP”) own­er, in the tele­com­mu­nic­a­tion.
CMS ad­vises Almir­all on multi-bil­lion ac­quis­i­tion of...
CMS adds 31 part­ners across the firm